TrialThe Lancet. Infectious diseases2020

Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trial.

Shabir A Madhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.